Albendazole and Generalised oedema - a phase IV clinical study of FDA data

Summary:

Generalised oedema is reported as a side effect among people who take Albendazole (albendazole), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Imipenem And Cilastatin, and have Filariasis lymphatic.

The phase IV clinical study analyzes which people have Generalised oedema when taking Albendazole. It is created by eHealthMe based on reports of 1,389 people who have side effects when taking Albendazole from the FDA, and is updated regularly.

What is Albendazole?

Albendazole has active ingredients of albendazole. eHealthMe is studying from 1,394 Albendazole users. Check the latest studies of Albendazole.

What is Generalised oedema?

Generalised oedema (swelling all over the body) is found to be associated with 1,090 drugs and 1,406 conditions by eHealthMe. Check the latest studies of Generalised oedema.

On Jul, 30, 2026

1,389 people reported to have side effects when taking Albendazole.
Among them, 15 people (1.08%) have Generalised oedema.

Could Albendazole cause Generalised oedema?

Among these 15 people:

How long have people been on Albendazole when they have Generalised oedema? *

What is the gender of people who have Generalised oedema when taking Albendazole? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Generalised oedema when taking Albendazole? *

What are other drugs people take besides Albendazole? *

Stavudine: 2 people, 13.33%
Pyridoxine: 2 people, 13.33%
Nevirapine: 2 people, 13.33%
Lamivudine: 2 people, 13.33%
Imipenem And Cilastatin: 2 people, 13.33%
Stromectol: 1 person, 6.67%
Lamprene: 1 person, 6.67%
Calcium Lactate: 1 person, 6.67%

What are other side effects people have besides Generalised oedema? *

Fever: 7 people, 46.67%
Erythema Multiforme (a type of hypersensitivity reaction): 6 people, 40.00%
Skin Exfoliation (removal of the oldest dead skin cells): 5 people, 33.33%
Itching: 5 people, 33.33%
Weakness: 3 people, 20.00%
Skin Ulcer: 3 people, 20.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 20.00%
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid): 2 people, 13.33%
Lip Ulceration (ulcer of lip): 2 people, 13.33%
Hypokalemia (low potassium): 2 people, 13.33%

What are the existing conditions these people have? *

Onchocerciasis (a parasitic disease caused by the filarial worm): 7 people, 46.67%
Filariasis Lymphatic (the presence of worms in the regional lymphatic vessels like wuchereria bancrofti, brugia malayi, and brugia timori): 7 people, 46.67%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 13.33%
Pinworms: 1 person, 6.67%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 1 person, 6.67%
Leprosy (a disfiguring disease caused by the mycobacterium leprae bacteria): 1 person, 6.67%
Hiv Infection: 1 person, 6.67%
Filariasis (a parasitic disease transmitted by blood -feeding arthropods, mainly black flies and mosquitoes): 1 person, 6.67%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Albendazole and have Generalised oedema?

- Check whether Generalised oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Albendazole:

Albendazole (1,394 reports)

Browse all side effects of Albendazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Generalised oedema:

Generalised oedema (1,090 drugs)

Browse all the conditions that are associated with Generalised oedema:

Generalised oedema (1,406 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albendazole (the active ingredients of Albendazole) and Albendazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.